Milk Oral Immunotherapy (OIT) plus Xolair® (anti-IgE) (ages 7-35 years)

ID Number 07-0563

Principal Investigator(s)
Hugh A Sampson

Department(s) or Division(s)


Prior research has shown that milk oral immunotherapy has been effective in treating milk allergy. This study will help us learn about the safety and medical effects of milk oral immunotherapy (OIT) alone and together with omalizumab (Xolair®). The study will look at possible differences such as the amount of milk that can be tolerated during feeding tests while on milk OIT and side effects during therapy. All participants will get milk oral immunotherapy. Study Page

Contact Information
Sally Noone
(212) 241-0336

Recruiting Patients: No